Since the expression of both GFP and Luc transgenes in tumor xenografts is driven by the same Nanog promoter, we intended to further quantify number of putative CSCs by determining the percentage of GFP-positive cells in paraffin-embedded section of tumor xenografts through GFP antibody-based staining method. The gene discussed is NANOG; the disease is neoplasm.